secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001140361-22-044329
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eterna closes ~$7.7M private placement with insider participation
-----------------------------------------------------------------

- Closed private placement of 2,184,950 units at $3.53/unit on Dec 2, 2022, raising ~$7.7M.
- Each unit consists of one share of common stock and two warrants exercisable at $3.28/share.
- Warrants exercisable after 6 months, expire June 2, 2028; include 4.99%/9.99% beneficial ownership limit.
- Chairman Cherington and director Singer participated on same terms as other investors.
- Net proceeds to be used for general working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000114036122044329/0001140361-22-044329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000114036122044329/brhc10045002_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-044329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer